Advancing maternal survival in the global context: are our strategies working?

BMC Public Health

Nancy L Sloan¹  Richard Derman³  Omar A Khan² 

[1] Epidemiologist, Department of Obstetrics & Gynecology, Christiana Care Health System, Department of Population & Family Health; Columbia University School of Public Health, New York, NY, USA;Department of Family & Community Medicine, Jefferson Medical College, Philadelphia, PA 19107, USA;Marie E. Pinizzotto Endowed Chair of Obstetrics and Gynecology and Director, Center for Women’s and Children’s Health Research, Christiana Care Health System; Professor, Obstetrics and Gynecology, Thomas Jefferson University, 4755 Ogletown-Stanton Road Suite 1903, Newark, DE 19713, USA

关键词: Child mortality;    Postpartum hemorrhage;    Maternal health;   

Others  :  1161993
DOI  :  10.1186/1471-2458-13-689

 received in 2013-02-06, accepted in 2013-07-18,  发布年份 2013

【 摘 要 】

There have been significant gains in improving maternal mortality over the last two decades. Researchers have suggested a variety of interventions and mechanisms to explain these improvements. While it is likely that much of what has been done in research and programs has contributed to this decline, the evidence regarding what works in the settings in which women deliver continues to face many challenges. We review the evidence for these improvements and suggest that there remain areas to focus on, particularly the births which currently take place in an unsupervised or substandard environments. We highlight the main areas where more evidence is needed, and end with a call to determine which of our interventions seem to have the most benefit; which do not; and where to invest future resources.

【 授权许可】

   
2013 Khan et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Trends in maternal mortality: 1990 to 2010: WHO, UNICEF, UNFPA and The World Bank estimates. Geneva: World Health Organization; 2012:25-26.
• [2]Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, Lopez AD, Lozano R, Murray CJ: Maternal mortality for 181 countries, 1980–2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010, 375(9726):1609-1623. Epub 2010 Apr 9
• [3]Pagel C, Lewycka S, Colbourn T, Mwansambo C, Meguid T, Chiudzu G, Utley M, Costello AM: Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet 2009, 374(9699):1441-1448. Epub 2009 Sep 23
• [4]Ronsmans C, Huang W: “Comment on ”Community-based interventions to reduce maternal mortality”. Lancet 2010, 375(9713):457. author reply 458–9
• [5]Braunholtz D, Graham W, Hussein J: Comment on “Community-based interventions to reduce maternal mortality”. Lancet 2010, 375(9713):457. author reply 458–9
• [6]Ahmed Y, Mwaba P, Grange J, Green C, Zumla A: Comment on “Community-based interventions to reduce maternal mortality”. Lancet 2010, 375(9713):457-458. author reply 458–9
• [7]Ronsmans C, Graham WJ: Lancet maternal survival series steering group. Maternal mortality: who, when, where, and why. Lancet 2006, 368(9542):1189-1200.
• [8]Graham WJ, Bell JS, Bullough CHW: Can skilled attendance reduce maternal mortality in developing countries? Stud Health Serv Organ Policy 2001, 17:97-131.
• [9]Schiffman J: Can poor countries surmount high maternal mortality? Stud Fam Plann 2000, 31(4):274-289.
• [10]Hatt L, Stanton C, Makowiecka K, Adisasmita A, Achadi E, Ronsmans C: Did the strategy of skilled attendance at birth reach the poor in Indonesia? Bull World Health Organ 2007, 85(10):774-782.
• [11]Hermida J, Salas B, Sloan NL: Sustainable scale-up of active management of the third stage of labor for prevention of postpartum hemorrhage in Ecuador. Int J Gynaecol Obstet 2012, 117(3):278-282. Epub 2012 Apr 6
• [12]Youngleson MS, Nkurunziza P, Jennings K, Arendse J, Mate KS, Barker P: Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition. PLoS One 2010, 5(11):e13891.
• [13]Lolekha R, Chunwimaleung S, Hansudewechakul R, Leawsrisook P, Prasitsuebsai W, Srisamang P, et al.: Pediatric HIVQUAL-T: measuring and improving the quality of pediatric HIV care in Thailand, 2005–2007. Jt Comm J Qual & Patient Safety 2010, 36(12):541-551. Ap1-7
• [14]Sloan NL, Ngoc NTN, Hieu DT, Quimby C, Winikoff B, Fassihian G: Effectiveness of life saving skills training and improving institutional emergency obstetric care readiness in lam dong, Vietnam. J Midwif Women’s Health 2005, 50:315-323.
• [15]Diadhiou M, Dieng T, Ortiz C, Mall I, Dione D, Sloan NL: Introduction of misoprostol for prevention of postpartum hemorrhage at the community level in Senegal. Int J Gynaecol Obstet 2011, 115(3):251-255. Epub 2011 Oct 7
• [16]Sloan NL, Winikoff B, Fikree FF: An ecologic analysis of maternal mortality ratios. Stud Fam Plann 2001, 32(4):352-355. 17
• [17]Bradshaw D, Chopra M, Kerber K, Lawn JE, Bamford L, Moodley J, Pattinson R, Patrick M, Stephen C, Velaphi S, South Africa Every Death Counts Writing Group: Every death counts: use of mortality audit data for decision making to save the lives of mothers, babies, and children in South Africa. Lancet 2008, 371(9620):1294-1304.
• [18]Miller S, Sloan NL, Langer A, Winikoff B, Fikree FF: Where is the “E” in MCH?: The need for an evidence-based approach in Safe motherhood. J Midwif Women’s Health 2003, 48:10-18.
• [19]Graham WJ: Measuring the impact of health interventions on mortality in developing countries: why bother? J Biosoc Sci 1989, 10(10):69-78.
• [20]World Health Organization: Promoting Optimal Fetal Development: Report of Technical Consultation. Geneva: WHO; 2006.
• [21]Graham W: Now or never. Lancet. 2002, 359:701-704.
• [22]West KP Jr, Katz J, Khatry SK, LeClerq SC, Pradhan EK, Shrestha SR, et al.: Double blind, cluster randomised trial of low dose supplementation with vitamin A or carotene on mortality related to pregnancy in Nepal. BMJ 1999, 318:570-575.
• [23]The Eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet 1995, 345:1455-1463.
• [24]Altman D, Carroli G, Duley L, The Magpie Trial Collaborative Group: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet 2002, 359:1877-1890.
• [25]Ronsmans C, Campbell O, Collumbien M: Effect of supplementation with vitamin A or beta carotene on mortality related to pregnancySlight modifications in definitions could alter interpretation of results. BMJ 1999, 319(7218):1202-1203.
• [26]Kirkwood BR, Hurt L, Amenga-Etego S, Tawiah C, Zandoh C, Danso S, Hurt C, Edmond K, Hill Z, Ten Asbroek G, Fenty J, Owusu-Agyei S, Campbell O, Arthur P: ObaapaVitA trial team. Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial. Lancet 2010, 375(9726):1640-1649.
• [27]West KP Jr, Christian P, Labrique AB, Rashid M, Shamim AA, Klemm RD, Massie AB, Mehra S, Schulze KJ, Ali H, Ullah B, Wu LS, Katz J, Banu H, Akhter HH, Sommer A: Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in rural Bangladesh: a cluster randomized trial. JAMA 2011, 305(19):1986-1995.
• [28]Awasthi S, Peto R, Read S, Clark S, Pande V, Bundy D, DEVTA (Deworming and Enhanced Vitamin A) team: Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet 2013, 381(9876):1469-1477. Epub 2013 Mar 14
• [29]Sommer A, West KP Jr, Martorell R: Vitamin A supplementation in Indian children. Lancet 2013. S0140-6736(13)60645-5. Epub ahead of print
• [30]Sloan NL, Durocher J, Aldrich T, Blum J, Winikoff B: What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG 2010, 117(7):788-800. Epub 2010 Apr 20
• [31]Majeed RW, Stöhr MR, Röhrig R: Proactive authenticated notifications for health practitioners: two way human computer interaction through phone. Stud Health Technol Inform 2012, 180:388-392.
• [32]D’souza S: A population laboratory for studying disease processes and mortality–the Demographic Surveillance System, Matlab Comilla. Bangladesh Rural Demogr 1981, 8(1):29-51.
• [33]Goudar SS, Carlo WA, McClure EM, Pasha O, Patel A, Esamai F, Chomba E, Garces A, Althabe F, Kodkany B, Sami N, Derman RJ, Hibberd PL, Liechty EA, Krebs NF, Hambidge KM, Buekens P, Moore J, Wallace D, Jobe AH, Koso-Thomas M, Wright LL, Goldenberg RL: The maternal and newborn health registry study of the global network for women’s and Children’s health research. Int J Gynaecol Obstet 2012, 118(3):190-193. Epub 2012 Jun 26
• [34]Oduro AR, Wak G, Azongo D, Debpuur C, Wontuo P, Kondayire F, Welaga P, Bawah A, Nazzar A, Williams J, Hodgson A, Binka F: Profile of the navrongo health and demographic surveillance system. Int J Epidemiol 2012, 41(4):968-976.
• [35]Yu P, de Courten M, Pan E, Galea G, Pryor J: The development and evaluation of a PDA-based method for public health surveillance data collection in developing countries. Int J Med Inform 2009, 78(8):532-542. Epub 2009 Apr 15
• [36]Peabody JW, Luck J: When do developing countries adopt managed care policies and technologies? Part I: policies, experience, and a framework of preconditions. Am J Manag Care 2002, 8(11):997-1007.